quartr
MDXG: Sanara MedTech acquisition positions the company for $400M+ revenue and 20%+ EBITDA margin in 2027
Announced acquisition of Sanara MedTech, creating a top regenerative medicine company with a strong surgical focus. Q2 saw sequential recovery in wound care and 15% YoY growth in surgical, with full-year guidance reiterated. Combined 2027 revenue expected to exceed $400 million with 20%+ EBITDA mar…